🇺🇸 FDA
Pipeline program

Arm 1: IL13Ra2-specific CAR Tcm cells

13384

Phase 1 mab active

Quick answer

Arm 1: IL13Ra2-specific CAR Tcm cells for Recurrent Glioblastoma is a Phase 1 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Recurrent Glioblastoma
Phase
Phase 1
Modality
mab
Status
active

Clinical trials